Embed Size (px)
Citation preview
DAILY SCIENTIFIC PROGRAMME FRIDAY 14 JUNE, 2019
AMBER 1 07:00-08:00
GRUPPO SIDeMaST DERMATOLOGIA ONCOLOGICA: Dermato-oncology update CO-CHAIRS: Francesco Lacarrubba (ITALY), Nicola Pimpinelli (ITALY)
07:00 Cutaneous Lymphomas: therapeutic update Nicola Pimpinelli (ITALY)
07:10 Discussion
07:15 Melanoma: news on adjuvant treatment Pietro Quaglino (ITALY)
07:25 Discussion
07:30 Advanced basal cell carcinoma: real life using vismodegib Maria Concetta Fargnoli (ITALY)
07:40 Discussion
07:45 Squamous cell carcinoma: news on adjuvant treatment Giuseppe Argenziano (ITALY)
07:55 Discussion
AMBER 2 07:00-08:00
GRUPPO SIDeMaST PATOLOGIE ANNESSIALI: SIDeMaST Group for Annexial Diseases CO-CHAIRS: Bianca Maria Piraccini (ITALY), Alfredo Rossi (ITALY)
07:00 What’s new on nails at the WCD 2019 Bianca Maria Piraccini (ITALY)
07:07 What’s new on hair at the WCD 2019 Maria Caterina Fortuna (ITALY), Alfredo Rossi (ITALY)
07:14 What’s new on tricoscopy and onychoscopy at the WCD 2019 Michela Starace (ITALY)
07:21 Mechanical (Physical) therapy for hair diseases Aurora Alessandrini (ITALY)
07:28 Treatment of nail in growing: from old to new approaches Paola Monari (ITALY)
07:35 News on nail unit melanoma Emi Dika (ITALY), Pier Alessandro Fanti (ITALY)
07:42 Inflammation: new target of Hidradenitis suppurativa pathogenesis Claudio Marasca (ITALY)
07:49 Discussion
AMBER 3 07:00-08:00
GRUPPO SIDeMaST DI IMMUNOLOGIA CUTANEA: Italian Immunopathology Group: working in progress CO-CHAIRS: Aurora Parodi (ITALY), Marzia Caproni (ITALY)
07:00 Pemphigoid induced by antidiabetics drugs Giovanni Di Zenzo (ITALY)
07:12 Discussion
07:15 Autoantibody Profile of a Cohort of Italian Patients with Linear IgA dermatosis Giulia Gasparini (ITALY)
07:27 Discussion
07:30 Cutaneous lupus erythematosus: the role of serologic testing in management and monitoring Marzia Caproni (ITALY)
07:42 Discussion
07:45 Circulating T helper and regulatory cells in patients with cutaneous adverse drug reactions: a multicentric flow cytofluorimetric study Paolo Fava (ITALY)
07:57 Discussion
AMBER 4 07:00-08:00
GILD: Laser application for the genital area CO-CHAIRS: Francesca Negosanti (ITALY), Giovanni Cannarozzo (ITALY)
07:00 Lasers in the genital pathology Ercole Costanza (ITALY), Mario Sannino (ITALY)
07:10 Lasers in genital lichen Sclerosus Nicoletta Banzola (ITALY)
07:20 Lasers in menopause genital syndrome Francesca Negosanti (ITALY)
07:30 Lasers and urinary disorders Debora Marchiori (ITALY)
07:40 Lasers and genital bleaching Miriam Leuzzi (ITALY)
07:50 Discussion
IS
IS
IS
IS
FRIDAY 14 JUNE, 2019
AMBER 5+6 07:00-08:00
Dermatology Olympics by AIDNID CO-CHAIRS: Alessandro Di Stefani (ITALY), Caterina Longo (ITALY)
Interactive session where dermatologists will compete against one another on providing the correct diagnosis based on seeing dermoscopic images displayed on a screen.
AMBER 7+8 07:00-08:00
ADOI: Precision medicine and biomarkers in dermatology CO-CHAIRS: Maurizio Congedo (ITALY), Marina Talamonti (ITALY)
07:00 Precision medicine in Dermatology: perspectives and problems Angela Filoni (ITALY)
07:20 Precision medicine in the treatment of psoriasis Cristina Albanesi (ITALY)
07:40 Atopic Dermatitis and Precision Medicine Giovanni Damiani (ITALY)
BROWN 1 07:00-08:00
GRUPPO SIDeMaST STORIA DELLA DERMATOLOGIA E VENEREOLOGIA: History of Dermatology CO-CHAIRS: Patrizia Forgione (ITALY), Massimo Nacca (ITALY)
07:00 Dermatology from prehistory: psoriasis and actinic keratosis Gioachino Alessandro Caresana (ITALY)
07:15 History of gonorrhea Valeria Gaspari (ITALY)
07:30 From Darwin to climate change: the bizarre story of atopic dermatitis Cataldo Patruno (ITALY)
07:45 History of women in Science and Dermatology Sabine Pabisch (ITALY)
AMBER 1 08:00-10:45
FELLOW FORUM 4 CO-CHAIRS: Simone Ribero (ITALY), Zoe Apalla (GREECE)
08:00 Efficacy of dual mode quasi-Long Pulsed & Q Switched 1064nm Nd: YAG laser as an adjuvant in management of Active Acne Vulgaris S. Chavan (INDIA)
08:15 Histoid Leprosy: A 12 Year Retrospective Clinical-Epidemiological Study and its association to lepra reactions E. Coelho (BRAZIL)
08:30 The impact of specific anatomical location on melanoma survival: independent high and low risk sites M. Howard (AUSTRALIA)
08:45 A new therapeutic approach with HIV-positive and immune compromised patients in the removal of genital warts, which protects doctors from professional exposure I. Jeremić (SERBIA)
09:00 The aquagenic pruritus in polycythemia vera: clinical characteristics E. Lelonek (POLAND)
09:15 Melanocyte and melanogenesis features in pigmented an non-pigmented variants of basal cell carcinoma K. Martinez-Rosales (MEXICO)
09:30 Successful treatment of teriflunomide-induced toxic epidermal necrolysis with accelerated elimination of the medication and cyclosporine R. D. Pride (UNITED STATES)
09:45 Successful Treatment of Recalcitrant Pediatric Generalized Pustular Psoriasis Patients with anti-TNF-α therapy: A Case Series from a Tertiary Center in Turkey G. P. Sun (TURKEY)
10:00 HLA associations and autoimmune blistering disease: Generality and Heterogeneity Y. Sun (CHINA)
10:15 Platelet-rich plasma (PRP) in male and female genital lichen sclerosus: the impact of tissue repair and sex difference in the therapeutic response and quality of life M. Tedesco (ITALY)
IS
IS
FFIS
FRIDAY 14 JUNE, 2019
10:30 Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march J. Grønlund Holm (DENMARK)
AMBER 2 08:00-10:45
Parasitic Infections Affecting the Skin CHAIR: Esther Von Stebut (GERMANY) CO-CHAIRS: Archana Singal (INDIA), Roberto Arenas (MEXICO)
08:00 Cutaneous Leishmaniasis: Epidemiology, disease burden, and skin defence mechanisms Esther Von Stebut (GERMANY)
08:15 Discussion
08:20 Cutaneous Leishmaniasis: clinical presentation and management Archana Singal (INDIA)
08:40 Discussion
08:49 Tropical lymphoedemas (LF and podoconoiosis) Claire Fuller (UNITED KINGDOM)
09:09 Discussion
09:18 Loopholes in the management of scabies: lessons from clinics Vijay Zawar (INDIA)
09:38 Discussion
09:47 Head Lice: a practical approach Roberto Arenas (MEXICO)
10:07 Discussion
10:16 Guidelines for the treatment of cutaneous larva migrans Stefano Veraldi (ITALY)
10:36 Discussion
AMBER 3 08:00-10:45
Granulomatous Disorders (Non-infectious) CHAIR: Lajos Kemeny (HUNGARY) CO-CHAIRS: Misha Rosenbach (UNITED STATES), Dae Hun Suh (KOREA, REPUBLIC OF)
08:00 The spectrum of non-infectious granulomatous diseases Lajos Kemeny (HUNGARY)
08:11 Histopathology of non-infectious granuloma formation Istvan Nemeth (HUNGARY)
08:33 Granulomatous cutaneous sarcoidosis Peter Elsner (GERMANY)
08:55 Necrobiosis lipoidica Cornelia Erfurt-Berge (GERMANY)
09:17 Granuloma annulare Daniel Torocsik (HUNGARY)
09:39 Reactive granulomatous dermatitis Misha Rosenbach (UNITED STATES)
10:01 Granulomatous vasculitis Robert Micheletti (UNITED STATES)
10:23 Granulomatous rosacea Dae Hun Suh (KOREA, REPUBLIC OF)
AMBER 4 08:00-10:45
Pruritus CHAIR: Martin Steinhoff (IRELAND) CO-CHAIRS: Gil Yosipovitch (UNITED STATES), Hiroyuki Murota (JAPAN)
08:00 Pruritus and the Brain-Skin Axis: What is new? Gil Yosipovitch (UNITED STATES)
08:20 Discussion
08:25 Pruritus and the Immune-Skin Axis: an Update Martin Steinhoff (IRELAND)
08:45 Discussion
08:50 Central transmission of itch Pedro Pereira (GERMANY)
09:05 Discussion
09:10 Challenges in pruritus treatment Hiroyuki Murota (JAPAN)
09:30 Discussion
09:35 Role of Neurokinins in pruritus Sonja Ständer (GERMANY)
09:55 Discussion
10:00 New developments for treatment of pruritus Thomas Luger (GERMANY)
10:20 Discussion
10:25 The itch patient – what we can do to improve quality of life Uwe Gieler (GERMANY)
10:40 Discussion
SY
SY
SY
FRIDAY 14 JUNE, 2019
AMBER 5+6 08:00-10:45
Photomedicine CHAIR: Thomas Schwarz (GERMANY) CO-CHAIRS: Sally H. Ibbotson (UNITED KINGDOM), Henry W. Lim (UNITED STATES)
08:00 New developments in photocarcinogenesis Chikako Nishigori (JAPAN)
08:36 New developments in photoprotection Steven Wang (UNITED STATES)
09:12 New developments in visible light Iltefat Hamzavi (UNITED STATES)
09:48 New developments in PDT Yolanda Gilaberte (SPAIN)
10:24 Discussion
AMBER 7+8 08:00-10:45
Vitiligo CHAIR: Mauro Picardo (ITALY) CO-CHAIRS: Samia Esmat (EGYPT), Suresh Joshipura (INDIA)
08:00 Introduction
08:05 Role of genes and epigenetics Rehab Hegazy (EGYPT)
08:18 Immunological aspects of vitiligo Julien Seneschal (FRANCE)
08:31 Non immunological aspects Mauro Picardo (ITALY)
08:44 Chemical and Environmental factors Tamio Suzuki (JAPAN)
08:57 Classification and clinical features: measuring vitiligo Nanja Van Geel (BELGIUM)
09:10 Discussion
09:25 When is vitiligo an emergency Samia Esmat (EGYPT)
09:38 Optimizing phototherapy Tasneem Mohammad (UNITED STATES)
09:51 Philosophy of depigmentation Ahmed Mohammed Al Issa (SAUDI ARABIA)
10:04 New trends in the treatment of vitiligo Thierry Passeron (NETHERLANDS)
10:17 Quality of life in vitiligo: the tip of an iceberg Suresh Joshipura (INDIA)
10:30 Discussion
BLUE 1 08:00-10:45
Advanced Dermatopathology CHAIR: Omar Sangueza (UNITED STATES) CO-CHAIRS: Giorgio Annessi (ITALY), Lorenzo Cerroni (AUSTRIA)
08:00 Cutaneous vasculitis, a brief tour of updated experiences Lawrence Gibson (UNITED STATES)
08:30 Pruritus under the microscope Dieter Metze (GERMANY)
09:00 How to approach papulosquamous lesions Yu-Hung Wu (CHINESE TAIPEI)
09:30 Paediatric Dermatopathology Sylvie Fraitag (FRANCE)
10:00 Unusual cutaneous lymphoproliferative disorders Lorenzo Cerroni (AUSTRIA)
10:15 Unusual cutaneous lymphoproliferative disorders Omar Sangueza (UNITED STATES)
10:30 Q&A
BLUE 2 08:00-10:45
Advanced Dermatological Surgery CHAIR: Roland Kaufmann (GERMANY) CO-CHAIRS: Gaston Galimberti (ARGENTINA), Kavita Mariwalla (UNITED STATES)
08:00 Introduction – Current challenges in Dermatosurgery Roland Kaufmann (GERMANY)
08:10 Nose and cheeks Anthony Benedetto (UNITED STATES)
08:30 Lips and Chin Elena Rossi (ITALY)
08:50 Eyelids and Eyebrows Selma Schuartz Cernea (BRAZIL)
09:05 Temples and frontal Skin Gaston Galimberti (ARGENTINA)
SY
CO
CO
SY
FRIDAY 14 JUNE, 2019
09:20 Ears Kavita Mariwalla (UNITED STATES)
09:35 Scalp Jurg Hafner (SWITZERLAND)
09:55 Trunk John Paoli (SWEDEN)
10:10 Extremities Roland Kaufmann (GERMANY)
10:25 Microscopically controlled surgery – Modifications and Indications Kai Munte (NETHERLANDS)
BROWN 1 08:00-10:45
Photoprotection CHAIR: Giuseppe Monfrecola (ITALY) CO-CHAIRS: Darrell Rigel (UNITED STATES), Jean Krutmann (GERMANY)
08:00 Introduction Giuseppe Monfrecola (ITALY)
08:05 Photoprotection beyond UV Jean Krutmann (GERMANY)
08:25 Discussion
08:30 Does higher SPF sunscreen make a significant difference in UV Protection? Darrell Rigel (UNITED STATES)
08:50 Discussion
08:55 Photoprotection for skin diseases: the era of dedicated photoprotectors Giovanni Leone (ITALY)
09:15 Discussion
09:20 Sunscreen as a consumer product: acceptability and compliance Vincent Richer (CANADA)
09:40 Discussion
09:45 Photoprotection strategy in the prevention of skin aging among Asians Akimichi Morita (JAPAN)
10:05 Discussion
10:10 The future of photoprotection Steven Wang (UNITED STATES)
10:30 Discussion
10:35 Conclusions Giuseppe Monfrecola (ITALY)
10:38 Conclusions Jean Krutmann (GERMANY)
10:41 Conclusions Darrell Rigel (UNITED STATES)
BROWN 2 08:00-10:45
Vasculitis and vasculopathy CHAIR: Cord Sunderkoetter (GERMANY) CO-CHAIRS: Tamihiro Kawakami (JAPAN), Warren Piette (UNITED STATES)
08:00 Nomenclature and provisional classification of vasculitides and vasculopathies Cord Sunderkoetter (GERMANY)
08:20 The Interplay of hemostasis, inflammation, and coagulation, with a clinical approach to unraveling the process Warren Piette (UNITED STATES)
08:40 Histological differences between different vasculitides Ko-Ron Chen (JAPAN)
09:00 Histological differences between different vasculopathies Carlo Francesco Tomasini (ITALY)
09:20 Cutaneous and systemic Vasculitis in Behcet’s disease Erkan Alpsoy (TURKEY)
09:40 Diagnostic algorithm for small vessel vasculitis with relation to the new D-CHCC Tamihiro Kawakami (JAPAN)
10:00 Management of immune-complex vasculitides David A. Wetter (UNITED STATES)
10:20 Management of livedo vasculopathy Mar Llamas-Velasco (SPAIN)
10:40 Discussion
BROWN 3 08:00-10:45
Rheumatology for the dermatologist CHAIR: Jan Dutz (CANADA) CO-CHAIRS: Maria Sole Chimenti (ITALY), Robert Strohal (AUSTRIA)
08:00 Introduction – Session structure and topics Jan Dutz (CANADA)
SY
SY
CO
FRIDAY 14 JUNE, 2019
08:05 Advances in classification and treatment of SLE Paola Conigliaro (ITALY)
08:25 Dermatomyositis: New features, new treatments Gianfranco Ferraccioli (ITALY)
08:45 Vasculitis: Clinical and pathologic features of ANCA positive vasculitis as related to the skin Andrea Saggini (ITALY)
09:05 Q&A
09:12 New Concepts in Psoriatic Arthritis: New pathogenetic mechanisms in Psoriatic arthritis Augusta Ortolan (ITALY)
09:32 Articular manifestations and clinimetric measures in Psoriatic arthritis Raffaele Scarpa (ITALY)
09:52 Imaging strategies in Psoriatic arthritis Maria Sole Chimenti (ITALY)
10:12 Treatments targets and treatments options in Psoriatic arthritis Roberta Ramonda (ITALY)
10:32 Q&A
RED 1+2 08:00-10:45
Paediatric Dermatology: From A to Z CHAIR: Ruth Murphy (UNITED KINGDOM) CO-CHAIRS: Jayakar Thomas (INDIA), Jemima Mellerio (UNITED KINGDOM)
08:00 Welcome and Overview of paediatric dermatology from neonates to adolescents Ruth Murphy (UNITED KINGDOM)
08:10 Welcome and Overview of paediatric dermatology from neonates to adolescents Jemima Mellerio (UNITED KINGDOM)
08:20 Welcome and Overview of paediatric dermatology from neonates to adolescents Jayakar Thomas (INDIA)
08:30 Nongenetic neonatal rashes and blisters Danielle Marcoux (CANADA)
08:50 Inherited blisters Jemima Mellerio (UNITED KINGDOM)
09:10 Ichthyoses Keith Choate (UNITED STATES)
09:30 Q&A
09:40 Atopic Dermatitis Sandipan Dhar (INDIA)
10:00 Hemangiomas Eulalia Baselga (SPAIN)
10:20 Psoriasis Jayakar Thomas (INDIA)
10:40 Q&A
SILVER 08:00-10:45
Trichoscopy CHAIR: Antonella Tosti (UNITED STATES) CO-CHAIRS: Lidia Rudnicka (POLAND), Rachita Dhurat (INDIA)
08:00 Introduction by Chair & Co-Chairs
08:05 Basic Trichoscopy structures Ana Pedrosa (PORTUGAL)
08:15 Alopecia areata Misaki Kinoshita-Ise (JAPAN)
08:25 Female pattern hair loss Rachita Dhurat (INDIA)
08:35 Trichotillomania Lidia Rudnicka (POLAND)
08:45 Infections and infestations Hoda Moneib (EGYPT)
08:55 Tinea capitis Daniel Asz Sigall (MEXICO)
09:05 LPP and its variants Rodrigo Pirmez (BRAZIL)
09:15 Folliculitis decalvans Sergio Vano-Galvan (SPAIN)
09:25 Pustular erosive dermatosis Bianca Maria Piraccini (ITALY)
09:35 Misterious black dots Martin Zaiac (UNITED STATES)
09:42 What Hair Transplant Surgeons Should Know Chinmanat Tangjaturonrusamee (THAILAND)
09:50 Dermoscopy of black scalp Ncoza Dlova (SOUTH AFRICA)
10:00 Dermoscopy guided biopsies Antonella Tosti (UNITED STATES)
CO
CO
FRIDAY 14 JUNE, 2019
10:08 Quiz cases Nino Lortkipanidze (GEORGIA)
10:18 Quiz cases YuliYa Ovcharenko (UKRAINE)
10:28 Quiz cases Tatiana Siliuk (RUSSIAN FEDERATION)
10:38 Final Remarks
SPACE 1 08:00-10:45
Atopic Eczema: pathogenesis and epidemiology CHAIR: Tilo Biedermann (GERMANY) CO-CHAIRS: Sara Brown (UNITED KINGDOM), Yoshiki Tokura (JAPAN)
08:00 Epidemiology of atopic eczema and its comorbidities: Have we arrived? Sinead M. Langan (UNITED KINGDOM)
08:25 Discussion
08:33 Where genes drive us: Understanding atopic eczema from the geneticist’s perspective Sara Brown (UNITED KINGDOM)
08:58 Discussion
09:06 The cutaneous barrier function in atopic eczema: Causes and consequences Yoshiki Tokura (JAPAN)
09:31 Discussion
09:39 The new treatment era of atopic eczema: Where do we stand, what can we expect? Tilo Biedermann (GERMANY)
10:04 Discussion
10:12 Diversity of atopic eczema: Impact on management Kwang Hoon Lee (KOREA, REPUBLIC OF)
10:37 Discussion
SPACE 2 08:00-10:45
Personalised Medicine for Actinic Keratoses CHAIR: Maria Concetta Fargnoli (ITALY) CO-CHAIRS: Nicole Basset-Seguin (FRANCE), Thomas Dirschka (GERMANY)
08:00 Molecular and clinico-pathological definition of AK field Thomas Dirschka (GERMANY)
08:20 Current treatment guidelines for AK Stephen Schumack (AUSTRIA)
08:40 New AK field treatments Daniel Mark Siegel (UNITED STATES)
09:00 How to improve efficacy and tolerability of photodynamic therapy Maria Concetta Fargnoli (ITALY)
09:20 AK in high-risk body sites Nicole Basset-Seguin (FRANCE)
09:40 AK in high-risk patient populations Stefano Piaserico (ITALY)
10:00 Long-term management and prevention of AK Lutz Schmitz (GERMANY)
10:20 Discussion
SPACE 3 08:00-10:45
Dermoscopy of Non Pigmented Lesions CHAIR: Josep Malvehy (SPAIN) CO-CHAIRS: Francisco Paschoal (BRAZIL), Babar Rao (UNITED STATES)
08:00 My dermoscopic approach in non-pigmented lesions Giuseppe Argenziano (ITALY)
08:15 Dermoscopic differential diagnosis of the pink lesions of the face Rainer Hofmann-Wellenhof (AUSTRIA)
08:30 Dermoscopic pattern of actinic keratosis Francisco Paschoal (BRAZIL)
08:45 Dermatoscopic features of non-pigmented basal cell carcinoma Monika Arenbergerova (CZECH REPUBLIC)
09:00 Diagnostic challenges of amelanotic melanoma Josep Malvehy (SPAIN)
09:15 Interactive cases I Babar Rao (UNITED STATES)
09:30 Dermoscopic features and patterns of poromas Cristina Carrera (SPAIN)
09:45 RCM and OCT for improving diagnosis and pre-surgical definition of non-pigmented skin cancers Nathalie De Carvalho (BRAZIL)
10:00 Dermatoscopy in inflammatory and other skin disorders Aimilios Lallas (GREECE)
SY
SY
SY
FRIDAY 14 JUNE, 2019
10:15 Dermoscopy of vascular lesions Alicia Barreiro (SPAIN)
10:30 Interactive cases II Iris Zalaudek (AUSTRIA)
SPACE 4 08:00-10:45
Neonatal Dermatology CHAIR: Margarita Larralde (ARGENTINA) CO-CHAIRS: Christine Bodemer (FRANCE), Julie Powell (CANADA)
08:00 Common dermatologic manifestations in newborns Rashmi Sarkar (INDIA)
08:20 Vascular diseases in neonates Julie Powell (CANADA)
08:40 Neonatal tumors that mimic vascular diseases Margarita Larralde (ARGENTINA)
09:00 Q&A
09:06 Mastocytosis Christine Bodemer (FRANCE)
09:26 Blistering disorders in newborns Arti Nanda (KUWAIT)
09:46 Neonatal injuries Mario Cutrone (ITALY)
10:06 The different faces of congenital histiocytosis Paula C. Luna (ARGENTINA)
10:26 View of mosaic diseases in the neonatal period Veronica Kinsler (UNITED KINGDOM)
WHITE 1 08:00-10:45
Viruses Affecting the Skin CHAIR: Jane Sterling (UNITED KINGDOM) CO-CHAIRS: Jose Rios-Yuil (PANAMA), Stephen Tyring (UNITED STATES)
08:00 Herpes viruses Omar Lupi da Rosa Santos (BRAZIL)
08:30 Papillomaviruses Jane Sterling (UNITED KINGDOM)
09:00 Polyomaviruses Stephen Tyring (UNITED STATES)
09:30 Q&A
09:35 HIV Kieron Leslie (UNITED STATES)
10:05 Tropical viruses Jose Rios-Yuil (PANAMA)
10:35 Q&A
WHITE 2 08:00-10:45
Pathogenesis of Psoriasis CHAIR: Antonio Costanzo (ITALY) CO-CHAIRS: Lars Iversen (DENMARK), Andy Blauvelt (UNITED STATES)
08:00 Genetics in psoriasis Antonio Costanzo (ITALY)
08:22 Monogenic forms of Psoriasis: do they exist? Hervé Bachelez (FRANCE)
08:44 Cytokine network Andy Blauvelt (UNITED STATES)
09:06 Psoriasis: an autoimmune or auto-inflammatory disease? Johann E. Gudjonsson (UNITED STATES)
09:28 Psoriasis going from an acute to a chronic disease Lars Iversen (DENMARK)
09:50 Pathogenesis behind the co-morbidities in psoriasis Paolo Gisondi (ITALY)
10:12 Psoriasis: from pathogenesis to targeted therapies Kilian Eyerich (GERMANY)
10:34 Conclusion and vision on the future
YELLOW 1 08:00-10:45
Anogenital Disorders CHAIR: Sue Cooper (UNITED KINGDOM) CO-CHAIRS: Lynne Margesson (CANADA), Gudula Kirtschig (GERMANY)
08:00 Introduction and welcome Sue Cooper (UNITED KINGDOM)
08:05 Lichen Sclerosus in females: Diagnosis and management Gayle Fischer (AUSTRALIA)
08:25 Lichen sclerosus in males: Diagnosis and management Christopher Bunker (UNITED KINGDOM)
08:45 Genital Lichen planus: An update Sue Cooper (UNITED KINGDOM)
SY
SY
SY
SY
FRIDAY 14 JUNE, 2019
09:05 Genital eczema and itch Aruna Venkatesan (UNITED STATES)
09:25 Hidradenitis Suppurativa Ditte Marie Saunte (DENMARK)
09:45 Genital ulcers: Diagnosis and management Lynne Margesson (CANADA)
10:05 Genital fissures and erosions: Differential diagnosis and treatment Gudula Kirtschig (GERMANY)
10:25 Challenging cases from the clinic
YELLOW 2 08:00-10:45
Cutaneous reactions to new drugs CHAIR: Bernhard Homey (GERMANY) CO-CHAIRS: Jennifer Nam Choi (UNITED STATES), Chia-Yu Chu (CHINESE TAIPEI)
08:00 Interesting cases and management strategies Vincent Sibaud (FRANCE)
08:20 Q&A
08:27 Cutaneous adverse events of EGFR inhibitors and other tyrosine kinase inhibitors Pietro Sollena (ITALY)
08:47 Q&A
08:54 Cutaneous adverse events of targeted anti melanoma drugs (BRAFi, MEKi) Mario E. Lacouture (UNITED STATES)
09:14 Q&A
09:21 Cutaneous Adverse Reactions Associated with Cancer Targeted Therapies: What's New? Chia-Yu Chu (CHINESE TAIPEI)
09:41 Q&A
09:48 Cutaneous adverse events of other non oncological new drugs Maja Mockenhaupt (GERMANY)
10:08 Q&A
10:15 Cutaneous reactions to immune checkpoint inhibitor therapy Jennifer Nam Choi (UNITED STATES)
10:35 Q&A
10:42 Final remarks
YELLOW 3 08:00-10:45
HIV Infection and AIDS CHAIR: Roy Chan (SINGAPORE) CO-CHAIRS: Anisa Mosam (SOUTH AFRICA), Vincent Piguet (CANADA)
08:00 Introduction
08:03 Update on HIV biology Vincent Piguet (CANADA)
08:18 Review of Global epidemiology of HIV infection Anisa Mosam (SOUTH AFRICA)
08:28 Update on Treatment of HIV infection Roy Chan (SINGAPORE)
08:43 Update on Prevention of HIV Benson Yeo (SINGAPORE)
08:53 Inflammatory Skin Conditions incl. IRIS Toby Maurer (UNITED STATES)
09:13 Break
09:23 Infectious Skin Conditions Ramesh Bhat (INDIA)
09:43 Kaposi’s sarcoma – an update Anisa Mosam (SOUTH AFRICA)
09:53 What's new in STIs in HIV infection Tatsuyoshi Kawamura (JAPAN)
10:13 Update in Adverse Cutaneous Drug Reactions Rannakoe Lehloenya (SOUTH AFRICA)
10:28 Q&A
10:43 Round up
SY
SY
FRIDAY 14 JUNE, 2019
FRIDAY 14 JUNE, 2019GOLD 11:00-12:30
CO-CHAIRS: Ricardo Galimberti (ARGENTINA), Irene Leigh (UNITED KINGDOM), Jean-Hilaire Saurat (SWITZERLAND), Jouni Uitto (UNITED STATES)
11:00 Discover of JAK/STAT pathway John O'Shea (UNITED STATES)
11:30 The Molecular Basis of Novel Therapies for Alopecia Angela Christiano (UNITED STATES)
11:50 Advances in the Treatment of Melanoma Caroline Robert (FRANCE)
12:10 How Laser and Photonic Technology will change Dermatology Rox Anderson (UNITED STATES)
AMBER 1 14:30-16:30
Skin Health and Ethics CO-CHAIRS: Martino Neumann (NETHERLANDS), Cecile Clavaud ( FRANCE)
14:30 Development of a scale to measure the psychosocial impact of vitiligo on family members S. Agrawal (INDIA)
14:40 Emotion dysregulation and mood pathology in Psoriasis. Implication for disease Management P. Amerio (ITALY)
14:50 The Impact of Wikipedia Editing in Dermatology M.O. Hutton (UNITED STATES)
15:00 Emerging dermatitis from mesostigmatic (arachnids: acari) in Italian urban settlements E. Castelli (ITALY)
15:10 New insight into the link between skin microbiota and pollution derived clinical disorders C. Clavaud (FRANCE)
15:20 Novel point of care diagnostic strategies for skin disease in low resource settings: portable confocal microscopy for Kaposi’s sarcoma E. Freeman (UNITED STATES)
15:30 Impact on Quality of Life in family members of Vitiligo patients J. Chandni (INDIA)
15:40 HIV epidemic in the Middle East and North Africa region: can we hide it? I. Maatouk (UNITED KINGDOM)
15:50 Predatory conferences: Caveat emptor! M. Pawar (INDIA)
16:00 Dermatitis artefacta in childhood and adolescence: a spectrum of disease P. Mohandas (UNITED KINGDOM)
16:10 A novel pedagogic approach assessing quality of care M. Singh (UNITED KINGDOM)
16:20 Dermatology Referrals from the Emergency Department at a Tertiary Care Hospital J. Tran (CANADA)
AMBER 2 14:30-16:30
Graft versus Host Disease CHAIR: Edward Cowen (UNITED STATES) CO-CHAIRS: Pietro Rubegni (ITALY), Sharon Hymes (UNITED STATES)
14:30 Introduction: overview of HSCT Edward Cowen (UNITED STATES)
14:50 Histopathology and biomarkers of GVHD Alejandro Gru (UNITED STATES)
15:05 Oral manifestations of GVHD Jacqueline Mays (UNITED STATES)
15:20 Skin-directed management of GVHD (or overview of HSCT) Sharon Hymes (UNITED STATES)
15:40 Management of pediatric GVHD Jennifer Huang (UNITED STATES)
15:55 Role of extracorporeal photopheresis in the treatment of GVHD Pietro Rubegni (ITALY)
16:10 Q&A
AMBER 3 14:30-16:30
Inherited Tumour Syndromes CHAIR: Neil Rajan (UNITED KINGDOM) CO-CHAIRS: Giovanni Ponti (ITALY) Raymond Cho (UNITED STATES)
WS
WS
FC
PL
14:30 Introduction Neil Rajan (UNITED KINGDOM)
14:33 Xeroderma Pigmentosum: Defects in the DNA Repair Machinery John Digiovanna (UNITED STATES)
14:53 Discussion
14:56 Interaction of inherited variants and somatic mutations in cutaneous tumors Raymond Cho (UNITED STATES)
15:16 Discussion
15:19 Mutated epigenetic modifiers in CYLD cutaneous syndrome Neil Rajan (UNITED KINGDOM)
15:39 Discussion
15:42 Basal cell naevus syndrome John Lear (UNITED KINGDOM)
16:02 Discussion
16:05 Birt-Hogg-Dube syndrome Maurice Van Steensel (SINGAPORE)
16:25 Discussion
16:28 Closing comments and summary Neil Rajan (UNITED KINGDOM)
AMBER 4 14:30-16:30
Hair Disorders in Skin of Colour CHAIR: Amy McMichael (UNITED STATES) CO-CHAIRS: Rodrigo Pirmez (BRAZIL), Ncoza Dlova (SOUTH AFRICA)
14:30 Introduction Amy McMichael (UNITED STATES)
14:35 Trichoscopy in skin of color Rodrigo Pirmez (BRAZIL)
14:50 CCCA updates Valerie Callender (UNITED STATES)
15:05 FFA and LPPigmentosus in skin of color patients Ncoza Dlova (SOUTH AFRICA)
15:20 Q&A
15:30 Interesting and Challenging Scalp Cases in India Rachita Dhurat (INDIA)
15:45 Impact of relaxers in women Sara Salas (MEXICO)
16:00 Implications of oils/natural products/shampoo additives on skin of color patients Amy McMichael (UNITED STATES)
16:15 Questions and close out Rodrigo Pirmez (BRAZIL)
AMBER 5+6 14:30-16:30
Managing Laser Complications CHAIR: Vishal Madan (UNITED KINGDOM) CO-CHAIRS: Steven Nisticò (ITALY), Amin Amer (EGYPT)
14:30 Managing Postinflammatory Hy-perpigmentation in Asian Skin Types Woraphong Manuskiatti (THAILAND)
14:45 Management of Risks in Vaginal Lasers Francesca Negosanti (ITALY)
15:00 Laser tattoo treatments, managing complications and what’s new? Keyvan Nouri (UNITED STATES)
15:15 Managing complications arising from laser resurfacing (fractional and non fractional) Mohamed Amer (EGYPT)
15:30 Assessing the safety of energy based devices (ultrasound, radio frequency, cryo lipolysis) and managing complications Jorge Ocampo-Candiani (MEXICO)
15:45 Intense pulsed light: risks and management Daniel Galimberti (ARGENTINA)
16:00 Improving safety in laser clinics what we must all do? Amin Amer (EGYPT)
16:15 Patient selection in Laser Dermatology - when is it time to say no! Vishal Madan (UNITED KINGDOM)
AMBER 7+8 14:30-16:30
Approach to classification and management of hypopigmentation CHAIR: Amit Pandya (UNITED STATES) CO-CHAIRS: Michelle Rodrigues (AUSTRALIA), Ayesha Akinkube (NIGERIA)
14:30 Presentations, signs of activity and differential diagnosis of vitiligo Michelle Rodrigues (AUSTRALIA)
WS
WS
WS
FRIDAY 14 JUNE, 2019
14:50 Medical management and phototherapy of vitiligo Amit Pandya (UNITED STATES)
15:10 Surgical management of vitiligo Nanja Van Geel (BELGIUM)
15:30 Q&A
15:40 Pityriasis versicolor, post-inflammatory hypopigmentation and medication-induced hypopigmentation Ayesha Akinkube (NIGERIA)
16:00 Nevus depigmentosus and idiopathic guttate hypomelanosis Hee Young Kang (KOREA, REPUBLIC OF)
16:20 Q&A
BLUE 1 14:30-16:30
Advanced Dermatopathology CHAIR: Omar Sangueza (UNITED STATES) CO-CHAIRS: Giorgio Annessi (ITALY), Lorenzo Cerroni (AUSTRIA)
14:30 Advances in dermatopathology of infectious disorders Francisco Bravo (PERU)
15:00 Histopathologic clues in the differential diagnosis of scarring alopecias Giorgio Annessi (ITALY)
15:30 Unusual observations in dermatopathology Lorenzo Cerroni (AUSTRIA)
16:00 Controversial issues on Melanocytic neoplasms Omar Sangueza (UNITED STATES)
BLUE 2 14:30-16:30
Advanced Dermatological Surgery CHAIR: Roland Kaufmann (GERMANY) CO-CHAIRS: Gaston Galimberti (ARGENTINA), Kavita Mariwalla (UNITED STATES)
14:30 Sentinel lymph node biopsy – standard approach and new developments David Ramirez Moreno (SPAIN)
14:55 Hidradenitis suppurativa – surgical approach Falk Bechara (GERMANY)
15:15 Varicose veins – update on available procedures Filippo de Pasquale (ITALY)
15:40 Surgery of the Nail Apparatus Judith Dominguez-Cherit (MEXICO)
16:05 Update on Hair replacement surgery Sung In Cho (KOREA, REPUBLIC OF)
BROWN 1 14:30-16:30
Diagnosis and Management of Dermatomyositis CHAIR: Ruth Ann Vleugels (UNITED STATES) CO-CHAIRS: Hector Chinoy (UNITED KINGDOM), Sueli Carneiro (BRAZIL)
14:30 Cutaneous Dermatomyositis: Diagnosis Clues for the Dermatologist Alisa N. Femia (UNITED STATES)
14:45 Update on Dermatomyositis and its Relationship with Malignancy Jeffrey Callen (UNITED STATES)
15:00 TIF1-gamma and NXP-2 antibodies and correlation with clinical phenotype in dermatomyositis Hector Chinoy (UNITED KINGDOM)
15:15 Q&A
15:30 MDA-5 antibody and correlation with clinical phenotype in dermatomyositis Manabu Fujimoto (JAPAN)
15:45 Advanced Treatment Pearls: Cutaneous Dermatomyositis Ruth Ann Vleugels (UNITED STATES)
16:00 Looking Forward: CDASI Validation and Clinical Trials for Dermatomyositis Victoria Werth (UNITED STATES)
16:15 Q&A
16:25 Concluding Remarks Sueli Carneiro (BRAZIL)
BROWN 2 14:30-16:30
Challenging Naevi CHAIR: Jason Rivers (CANADA) CO-CHAIRS: Kelly Cordoro (UNITED STATES), Gianluigi Giovene (ITALY)
14:30 Challenges in the histologic diagnosis of melanocytic nevi Clay J. Cockerell (UNITED STATES)
14:45 Q&A
CO
WS
WS
CO
FRIDAY 14 JUNE, 2019
14:50 Challenging Nevi Through the Ages Peter Soyer (AUSTRALIA)
15:05 Q&A
15:10 Challenges in the diagnosis and management of Congenital Nevi Enzo Erricchetti (ITALY)
15:25 Q&A
15:30 Challenges in the diagnosis & management of Nail & Acral Nevi Alex Chamberlain (AUSTRALIA)
15:45 Q&A
15:50 Atypical Nevi: State of the art in 2019 Ashfaq Marghoob (UNITED STATES)
16:05 Q&A
16:10 Aids to the diagnosis of challenging nevi Giuseppe Argenziano (ITALY)
16:25 Q&A
BROWN 3 14:30-16:30
Advanced Techniques and Risks: Fillers and Toxins CHAIR: Doris Hexsel (BRAZIL) CO-CHAIRS: Rebecca Fitzgerald (UNITED STATES), Domenico Piccolo (ITALY)
14:30 Introduction Doris Hexsel (BRAZIL)
14:35 Imaging and Photographic Documentation of Cosmetic Patients Domenico Piccolo (ITALY)
14:45 2D to 3D: Ovalizing the Face with Injectable Agents Rebecca Fitzgerald (UNITED STATES)
14:55 A Natural and Safe Approach with Fillers and Toxins for the Upper Face Andrè Braz (BRAZIL)
15:05 A natural Approach to Mid face and Tear Trough Fillers Vince Bertucci (CANADA)
15:15 Filling the Nose Davi De Lacerda (BRAZIL)
15:25 Fillers and Toxins for the Lower Face Ada Trinidade de Almeida (BRAZIL)
15:35 Advanced Techniques on Hands Mitchel Goldman (UNITED STATES)
15:45 Scars Treatments with Fillers and Toxins Joely Kaufman (UNITED STATES)
15:55 Complications of Fillers Joel Cohen (UNITED STATES)
16:05 Complications of Botulinum Toxins in Cosmetic and Medical Treatments Maurizio Benci (ITALY)
16:15 Q&A
RED 1+2 14:30-16:30
Paediatric Dermatology: From A to Z CHAIR: Ruth Murphy (UNITED KINGDOM) CO-CHAIRS: Jayakar Thomas (INDIA), Jemima Mellerio (UNITED KINGDOM)
14:30 Welcome back Ruth Murphy (UNITED KINGDOM)
14:35 Melanocytic nevi Veronica Kinsler (UNITED KINGDOM)
14:57 Cutaneous Leishmaniasis, leprosy and TB Johannes Dayrit (PHILIPPINES)
15:09 Drug reactions Antonio Torrelo (SPAIN)
15:31 Alopecia areata and Vitiligo Brett King (UNITED STATES)
15:53 Connective tissue Ruth Murphy (UNITED KINGDOM)
16:15 Q&A
SPACE 1 14:30-16:30
Hidradenitis suppurativa: The spectrum of management CHAIR: Gregor Jemec (DENMARK) CO-CHAIRS: Brian Kirby (IRELAND), Klemens Rappersberger (AUSTRIA)
14:30 Which out-comes should we assess Linnea Thorlacius (DENMARK)
14:48 Guidelines Gregor Jemec (DENMARK)
15:05 Surgery for HS Stanislav Tolkachjov (UNITED STATES)
15:22 Complications in HS surgery and how to avoid them Antonia Wiala (AUSTRIA)
CO
WS
WS
FRIDAY 14 JUNE, 2019
15:39 Biologics beyond TNF blockade Brian Kirby (IRELAND)
15:56 Light based therapy Hessel Van Der Zee (NETHERLANDS)
16:13 The role of antibiotics Dunja Vekic (AUSTRIA)
SPACE 2 14:30-16:30
Skin Signs of Systemic Disease CHAIR: Daniela Kroshinsky (UNITED STATES) CO-CHAIRS: Athanassios Kolivras (BELGIUM), Joseph Jorizzo (UNITED STATES)
14:30 Introduction Daniela Kroshinsky (UNITED STATES)
14:34 Alopecia as a Manifestation of Systemic Disease Athanassios Kolivras (BELGIUM)
14:54 Paraneoplastic Skin Diseases Lindsay Strowd (UNITED STATES)
15:14 Disseminated cutaneous nodules Xinaida Lima (BRAZIL)
15:34 Neutrophilic Dermatoses Joseph Jorizzo (UNITED STATES)
15:54 Painful skin ulcers in a patient with kidney disease Daniela Kroshinsky (UNITED STATES)
16:14 Q&A
SPACE 3 14:30-16:30
Mohs Surgery Update CHAIR: Brett Coldiron (UNITED STATES) CO-CHAIRS: Eduardo Nagore (SPAIN), Antonio Rusciani (ITALY)
14:30 Introduction Brett Coldiron (UNITED STATES)
14:38 Mohs Surgery in Brazil Luis Tovo (BRAZIL)
14:52 Mohs Surgery in Mexico Jorge Ocampo-Candiani (MEXICO)
15:06 Mohs Surgery in South Africa Pieter Du Plessis (SOUTH AFRICA)
15:20 Mohs Surgery in Indonesia Adhimukti Sampurna (INDONESIA)
15:34 Difficult Mohs Cases from America Brett Coldiron (UNITED STATES)
15:48 Difficult Mohs Cases from Italy Antonio Rusciani (ITALY)
16:02 Difficult Mohs Cases from Spain Eduardo Nagore (SPAIN)
16:16 Difficult Mohs Cases from Mexico Jose Fernando Barba Flores (MEXICO)
SPACE 4 14:30-15:30
Lentigo Maligna: Surgery or Not? CHAIR: David M. Pariser (UNITED STATES) DISCUSSANT: Against - Emma Craythorne (UNITED KINGDOM) For - Myrto-Georgia Trakatelli (GREECE), Cristina Magnoni (ITALY)
SPACE 4 15:30-16:30
Does Mole Mapping Make a Difference? CHAIR: Raúl Alejandro Cabrera Moraga (CHILE) DISCUSSANT: Against - Jean Jacques Grob (FRANCE), For - Gabriel Salerni (ARGENTINA)
WHITE 1 14:30-16:30
Immunobullous Clinic CHAIR: Detlef Zillikens (GERMANY) CO-CHAIRS: Evandro Rivitti (BRAZIL), Liangdan Sun (CHINA)
14:30 New insights into the pathogenesis of pemphigus Masayuki Amagai (JAPAN)
14:50 New insights into the pathogenesis and epidemiology of endemic pemphigus foliaceus Valeria Aoki (BRAZIL)
15:10 Current and novel treatment options for pemphigus Pascal Joly (FRANCE)
15:30 New insights into the pathogenesis of pemphigoid diseases Christian Sadik (GERMANY)
15:50 Mucous membrane pemphigoid: clinical spectrum and diagnosis Jane Setterfield (UNITED KINGDOM)
WS
CN
CN
WS
WS
FRIDAY 14 JUNE, 2019
16:10 Current and novel treatment options of bullous and mucous membrane pemphigoid Matthias Goebeler (GERMANY)
WHITE 2 14:30-16:20
Mucosal diseases and skin manifestations of internal disorders CO-CHAIRS: Emanuele Claudio Cozzani (ITALY), Giovanna Zambruno (ITALY)
14:30 Rituximab in the treatment of Rosai-Dorfman Disease with IgG4 H. Al-Kutubi (UNITED KINGDOM)
14:40 Setting future research priorities for lichen sclerosus R. Simpson (UNITED KINGDOM)
14:50 Calciphylaxis in daily practice: deal with it! V. Girgenti (ITALY)
15:00 Mucocutaneous manifestations in course of celiac disease: a clinical study of 280 patients M. Khallaayoune (MOROCCO)
15:10 Melkersson-Rosenthal syndrome: a retrospective study of 35 patients showing treatment outcomes, and indicating lingua plicata rather than orofacial swelling as the initial sign S. Kılıç (TURKEY)
15:20 Cutaneous metastases of internal cancers. Clinical, videodermoscopical and histopathological pictures of selected cases with literature review M. Maj (POLAND)
15:30 Paraneoplastic erythroderma: report of three cases D. Miyashiro (BRAZIL)
15:40 Study of cutaeneous manifestation in patients of chronic liver diseasec (CLD): a prospective observational study V. Naik (INDIA)
15:50 Platelet-rich plasma for the treatment of male genital lichen sclerosus resistant to conventional therapy in Uruguay: Preliminary results from the first pilot study J. Navarrete (URUGUAY)
16:00 Necrobiosis lipoidica beyond diabeticorum: A multi-institution evaluation of the clinical features and comorbidities of 236 patients C. Nelson (UNITED STATES)
16:10 Study of cutaneous manifestations of internal malignancies and of their treatments– a hospital based, prospective cross-sectional study N. Prabhu (INDIA)
YELLOW 1 14:30-16:30
Infectious diseases 2 CO-CHAIRS: Klaus Eisendle (ITALY), Dilip Shah (INDIA)
14:30 Bioterrorism: A Dermatologists Perspective - An Aid to Early Detection A. Chopra (INDIA)
14:40 Cutaneous Histoplasmosis: Review of Cases and Clinical Experience A. J. Rodrigues Queiróz (BRAZIL)
14:50 Dermatological manifestations of enterovirus infection: clinical presentation and possible long term sequelae in adult patients G. Ciccarese (ITALY)
15:00 A comprehensive analysis of testicular dysfunction in Indonesian men affected by leprosy H. Gunawan (INDONESIA)
15:10 Relevance of clindamycin in the skin and soft tissue infections by Beta haemolytic streptococci S. Shenoy (INDIA)
15:20 Pilot Study to Assess the Accuracy and Precision of Phenolic Glycolipid-I of Mycobacterium leprae Test Kit in Diagnosing New Leprosy Cases Among Patients at the Jose R. Reyes Memorial Medical Center M. Krisha Montenegro (PHILIPPINES)
15:30 Paediatric leprosy – peek a boo to leprosy transmission V. Chugh (INDIA)
15:40 Pain related to Varicella Zoster Virus reactivation: comparison between typical herpes zoster and zoster sine herpete A. Herzum (ITALY)
15:50 Classical today, unclassical tomorrow - An agent turning the diagnosis upside down B. Koneti (INDIA)
FCFC
FRIDAY 14 JUNE, 2019
16:00 Atypical manifestations of cutaneous tuberculosis: a case series of seven patients P. Verma (INDIA)
16:10 Nail infestation: An atypical presentation of typical scabies Y. Zou (CHINA)
16:20 Leprosy Scenario at a Tertiary Care Hospital in Mumbai: A 5-year Retrospective Study U. Zambare (INDIA)
YELLOW 2 14:30-16:30
Psoriasis 2 CO-CHAIRS: Luca Bianchi (ITALY), Alessandro Giunta (ITALY)
14:30 Conserved overall effectiveness of systemic therapies in elderly psoriasis patients - a two country, multi-center, prospective, non interventional study C. Sorbe (GERMANY)
14:40 The prevalence of John Cunningham (JC) virus antibody positivity in psoriasis patients O. Molloy (IRELAND)
14:50 Immunological and genetic profiles of drug induced paradoxical psoriasis L. Fania (ITALY)
15:00 Is there any difference between antiTNF-α induced paradoxical psoriasiform reactions and psoriasis? L. L. Tirelli (ARGENTINA)
15:10 Topical treatment with vitamin D3 analogue decreases MDR1-expressing T cells infiltrating in plaque psoriasis T. Fujiyama (JAPAN)
15:20 Importance of follow up in determining PsA prevalence of PsA in Turkish psoriasis patients B. Gunes (TURKEY)
15:30 An International Delphi survey to define screening for psoriatic arthritis and measurement of psoriatic arthritis symptoms in psoriasis clinical trials L. Perez-Chada (UNITED STATES)
15:40 Risk of Mycosis Fungoides in Psoriasis Patients C. Massone (ITALY)
15:50 CD8+CD69+ TRM cells hold immunological memory by IL-15 in psoriatic recurrence Z. Shen (CHINA)
16:00 Severe psoriasis is associated with gastrointestinal symptoms, intestinal barrier dysfunction and increased plasma concentration of gut microbiota-derived metabolites M. Sikora (POLAND)
16:10 Clinical response of fumaric acid esters in psoriasis: Registry data from 1,409 patients in Germany C. Sorbe (GERMANY)
16:20 Involvement of autoinflammation in early phases of psoriasis D. Fanoni (ITALY)
YELLOW 3 14:30-16:30
Atopic and contact dermatitis CO-CHAIRS: Luca Stingeni (ITALY), Marina Papoutsaki (ITALY)
14:30 Achieving an itch-free state with upadacitinib: a post-hoc analysis of data from the Phase 2b randomized, double-blind, placebo-controlled trial in moderate-to-severe atopic dermatitis K. Reich (GERMANY)
14:40 Atopic Eczema: genetic analysis of COL6A5, COL8A1 and COL10A1 in Mediterranean populations C. Strafella (ITALY)
14:50 Association of specific dietary behaviours with atopic dermatitis in adolescence: Results from the Korea Youth Risk Behavior Web-Based Survey (KYRBWS), 2017 S. Cho (KOREA, REPUBLIC OF)
15:00 Tralokinumab Phase 2b study: Effects of the anti-interleukin-13 monoclonal antibody on Staph. Aureus skin colonisation and systemic levels of inflammatory biomarkers in patients with atopic dermatitis A. Wollenberg (GERMANY)
15:10 Claudin-5 Deficiency induced by MicroRNA-224 5p Contributed to Defective Permeability Barrier in Sensitive Skin L. He (CHINA)
15:20 12-Week Efficacy and Safety Data of Ruxolitinib Cream in Adult Patients With Atopic Dermatitis: Results From a Phase 2 Study L. Kircik (UNITED STATES)
FC
FC
FRIDAY 14 JUNE, 2019
15:30 Allergic and photoallergic contact dermatitis to topical non-steroidal anti-inflammatory drugs: a case series from Turkey A. Kutlay (TURKEY)
15:40 Reconstructed human epidermis models with Langerhans cells (SkinEthic RHE-LC) C. Pellevoisin (FRANCE)
15:50 Safety of Dupilumab in Moderate-to-Severe Atopic Dermatitis Patients Inadequately Controlled With, Intolerant to, or Inadvisable for Cyclosporine-A: Laboratory Findings From the LIBERTY-AD-CAFÉ Trial K. Reich (GERMANY)
16:00 Study of the association of humanmicrobiome with nickel allergies overweight and metabolic syndrome A. Tammaro (ITALY)
16:10 Efficacious and well-tolerated treatment of chronic hand eczema and related itch with topical delgocitinib P. Elsner (GERMANY)
16:20 Identification of TMEM232 gene associated with atopic dermatitis through targeted capture sequencing and HaCaT cells experiment F. L. Xiao (CHINA)
FRIDAY 14 JUNE, 2019
